Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: A multicentre, prospective study

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Hansen, Marco Bo ^a   Rasmussen, Lars Simon ^a   Svensson, Mattias ^b   Chakrakodi, Bhavya ^b   Bruun, Trond ^c   Madsen, Martin Bruun ^a   Perner, Anders ^a   Garred, Peter ^a   Hyldegaard, Ole ^a   Norrby Teglund, Anna ^b   Nekludov, Michael ^b   Arnell, Per ^d   Rosén, Anders ^d   Oscarsson, Nicklas ^d   Karlsson, Ylva ^e   Oppegaard, Oddvar ^c   Skrede, Steinar ^c   Itzek, Andreas ^f   Wahl, Anna Mygind ^a   Hedetoft, Morten ^a   Bærnthsen, Nina Falcon ^a   Müller, Rasmus ^a   Nedrebø, Torbjørn ^g   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e BLEKINGE HOSPITAL   (Sweden)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^g Haraldsplass Deaconess University College Bergen   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

AGED; AMPUTATION; BLOOD; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NECROTIZING FASCIITIS; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SEPTIC SHOCK; SEVERITY OF ILLNESS INDEX; SOFT TISSUE INFECTION; STATISTICS AND NUMERICAL DATA; STREPTOCOCCUS INFECTION; SURVIVAL ANALYSIS;

AGED; AMPUTATION; BIOMARKERS; FASCIITIS, NECROTIZING; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SOFT TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85012000645     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42179     Document Type: Article

References (40)

1. Das, D. K., Baker, M. G. & Venugopal, K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J. Infect. 63, 429-433 (2011).
2. Oud, L. & Watkins, P. Contemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort study. Crit Care Res Pract 2015, 618067 (2015).
3. Luca-Harari, B. et al. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46, 79-86 (2008).
4. Bruun, T. et al. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clin. Microbiol. Infect. 19, E545-550 (2013).
5. Anaya, D. A. & Dellinger, E. P. Necrotizing soft-tissue infection: diagnosis and management. Clin. Infect. Dis. 44, 705-710 (2007).
6. Johansson, L., Thulin, P., Low, D. E. & Norrby-Teglund, A. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin. Infect. Dis. 51, 58-65 (2010).
7. Morgan, M. S. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J. Hosp. Infect. 75, 249-257 (2010).
8. Pierrakos, C. & Vincent, J.-L. Sepsis biomarkers: a review. Crit Care 14, R15 (2010).
9. Lungstras-Bufler, K. et al. High cytokine levels at admission are associated with fatal outcome in patients with necrotizing fasciitis. Eur. Cytokine Netw. 15, 135-138 (2004).
10. Rodriguez, R. M. et al. A pilot study of cytokine levels and white blood cell counts in the diagnosis of necrotizing fasciitis. Am J Emerg Med 24, 58-61 (2006).
11. Goh, T., Goh, L. G., Ang, C. H. & Wong, C. H. Early diagnosis of necrotizing fasciitis. Br J Surg 101, e119-125 (2014).
12. Wong, C.-H., Khin, L.-W., Heng, K.-S., Tan, K.-C. & Low, C.-O. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit. Care Med. 32, 1535-1541 (2004).
13. Su, Y.-C. et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg 78, 968-972 (2008).
14. Kincius, M., Telksnys, T., Trumbeckas, D., Jievaltas, M. & Milonas, D. Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene. Surg Infect (Larchmt), doi: 10.1089/sur.2015.076 (2016).
15. Thomas, A. J. & Meyer, T. K. Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis. Laryngoscope 122, 2683-2687 (2012).
16. Tsai, Y.-H., Hsu, R. W.-W., Huang, K.-C. & Huang, T.-J. Laboratory indicators for early detection and surgical treatment of vibrio necrotizing fasciitis. Clin. Orthop. Relat. Res. 468, 2230-2237 (2010).
17. Holland, M. J. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care 37, 588-592 (2009).
18. Sandner, A., Moritz, S., Unverzagt, S., Plontke, S. K. & Metz, D. Cervical Necrotizing Fasciitis-The Value of the Laboratory Risk Indicator for Necrotizing Fasciitis Score as an Indicative Parameter. J. Oral Maxillofac. Surg. 73, 2319-2333 (2015).
19. Harbarth, S. et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am. J. Respir. Crit. Care Med. 164, 396-402 (2001).
20. Behnes, M. et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 18, 507 (2014).
21. Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (1999).
22. Reinhart, K., Meisner, M. & Brunkhorst, F. M. Markers for sepsis diagnosis: what is useful? Crit Care Clin 22, 503-519 (2006).
23. Glass, G. E., Sheil, F., Ruston, J. C. & Butler, P. E. M. Necrotising soft tissue infection in a UK metropolitan population. Ann R Coll Surg Engl 97, 46-51 (2015).
24. Kittang, B. R. et al. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin. Microbiol. Infect. 17, 358-364 (2011).
25. Hasham, S., Matteucci, P., Stanley, P. R. W. & Hart, N. B. Necrotising fasciitis. BMJ 330, 830-833 (2005).
26. Elliott, D. C., Kufera, J. A. & Myers, R. A. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann. Surg. 224, 672-683 (1996).
27. Wong, C.-H. et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85-A, 1454-1460 (2003).
28. Alejandria, M. M., Lansang, M. A. D., Dans, L. F. & Mantaring, J. B. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev CD001090, doi: 10.1002/14651858.CD001090.pub2 (2013).
29. Kaul, R. et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28, 800-807 (1999).
30. Darenberg, J. et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, doubleblind, placebo-controlled trial. Clin. Infect. Dis. 37, 333-340 (2003).
31. Linner, A., Darenberg, J., Sjolin, J., Henriques-Normark, B. & Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin. Infect. Dis. 59, 851-857 (2014).
32. Koch, C. et al. Intravenous immunoglobulin in necrotizing fasciitis - A case report and review of recent literature. Ann Med Surg (Lond) 4, 260-263 (2015).
33. Norrby-Teglund, A. et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand. J. Infect. Dis. 37, 166-172 (2005).
34. Chella Krishnan, K. et al. Genetic Architecture of Group A Streptococcal Necrotizing Soft Tissue Infections in the Mouse. PLoS Pathog. 12, e1005732 (2016).
35. Hansen, M. B. et al. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Crit Care 20, 40 (2016).
36. Hansen, M. B. et al. The Lectin Complement Pathway in Patients with Necrotizing Soft Tissue Infection. J Innate Immun, doi: 10.1159/000447327 (2016).
37. Bozkurt, O., Sen, V., Demir, O. & Esen, A. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier's gangrene. Int Urol Nephrol 47, 243-248 (2015).
38. Le Gall, J. R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270, 2957-2963 (1993).
39. Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22, 707-710 (1996).
40. Hansen, M. B., Simonsen, U., Garred, P. & Hyldegaard, O. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study. BMJ Open 5, e006995 (2015).